Article

Effects of BET Inhibitor JQ1 and Interleukin-6 on Breast Cancer Cells

2021-12-28

Abstract excerpt

<title>Abstract</title> <p>Bromodomain and extra-terminal (BET) proteins are recognized acetylated lysine of histone 4 and act as scaffolds to recruit many other proteins to promoters and at enhancers of active genes, especially at the super-enhancers of key genes, driving the transcription process and have been identified as potential therapeutic targets in breast cancer. However, the efficacy of BET inhibitors...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c5cd773f-3a70-5799-a5c4-b9a255657135
DOI: 10.21203/rs.3.rs-1143331/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effects of BET Inhibitor JQ1 and Interleukin-6 on Breast Cancer CellsDOI 10.21203/rs.3.rs-1143331/v1Read

BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cells.Semantic proximity Read

BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemiaSemantic proximity Read

Bromodomain inhibitor JQ1 reversibly blocks IFN-γ productionSemantic proximity Read

Novel mechanistic targets of Forkhead box Q1 transcription factor in human breast cancer cellsSemantic proximity Read

The Functions of BET Proteins in Gene Transcription of Biology and DiseasesSemantic proximity Read

<i>In Silico</i> Analysis Guides Selection of BET Inhibitors for Triple-Negative Breast Cancer TreatmentSemantic proximity Read

Domain-selective targeting of BET proteins in cancer and immunological diseasesSemantic proximity Read

Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotypeSemantic proximity Read

Integration of the Transcriptome and Genome-Wide Landscape of BRD2 and BRD4 Binding Motifs Identifies Key Superenhancer Genes and Reveals the Mechanism of Bet Inhibitor Action in Rheumatoid Arthritis Synovial FibroblastsSemantic proximity Read

Precision Targeting of BET Proteins - Navigating Disease Pathways, Inhibitor Insights, and Shaping Therapeutic Frontiers: A Comprehensive ReviewSemantic proximity Read

BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1Semantic proximity Read

Inhibition of Bromodomain Proteins for the Treatment of Human Diffuse Large B-cell LymphomaSemantic proximity Read